Stem cells and hyperlipidaemia: Cheongdam Cell Clinic's perspective

Hyperlipidaemia appears alongside hypertension and diabetes on Cheongdam Cell Clinic's list of age-related conditions on its 淸(Rejuvenation)CELL programme page. The clinic groups these together because all three relate to vascular health and long-term cardiovascular risk.

Hyperlipidaemia refers to abnormally high LDL cholesterol or triglyceride levels, a major risk factor for atherosclerosis leading to heart disease and stroke. The mechanism the clinic proposes is that stem cells help repair vessel walls damaged by lipid accumulation — but this remains a hypothesis unproven in large, publicly published trials.

The internationally accepted approach to hyperlipidaemia remains statins or other lipid-lowering drugs as appropriate, combined with reducing saturated and trans fats, increasing fibre, and regular exercise. Periodic lipid-profile testing remains necessary for monitoring regardless of whether any supplementary programme is also pursued.

The clinic explains the 淸(Rejuvenation)CELL programme uses the patient's own bone-marrow stem cells, isolated without culturing, then reinjected within half a day. Its main selling points are speed and the safety of using autologous cells, aimed at people wanting general vascular health support rather than a treatment specific to hyperlipidaemia alone.

Patients with hyperlipidaemia who are on statins should disclose the drug type, dosage and recent lipid-test results to the clinic's doctors before deciding, so the overall vascular health picture can be assessed more completely and safely.

The phrase 'prevent and treat' on the clinic's website is the clinic's own marketing language, not accompanied by verifiable medical research citations. Interested patients should ask the clinic directly whether it has follow-up data on hyperlipidaemic patients who took this programme, and should also consult a cardiologist in Thailand before deciding.

Viewing this programme as a supplement to overall vascular health care alongside existing standard treatment helps patients set reasonable expectations, rather than treating it as a substitute for lipid-lowering medication.

Before travelling to Seoul, patients should bring recent lipid-test results, a medication list and any family history of heart or vascular disease for the clinic to assess, and request cost details in writing, since the clinic does not publish prices publicly.